LONDON, Dec. 1, 2025 -- Oxford Instruments announces the release of Imaris 11, the latest generation of its industry-leading 3D/4D microscopy image visualisation and analysis software. The new version introduces an intuitive Workflow system, enhanced batch processing, and advanced tools for object detection and data exploration—designed to help researchers across the region achieve faster, more reproducible, and higher-quality insights. Imaris 11 supports the rapidly expanding life science and biotechnology ecosystems in Southeast Asia by enabling streamlined data analysis, imp
[ 메디채널 김갑성 기자 ] 런던 2025년 12월 1일 -- 옥스포드 인스트루먼츠(Oxford Instruments)가 3D 이미지 분석 및 이미지 시각화 기능을 강화한 최신 버전의 현미경 분석 소프트웨어, Imaris 11(이마리스 11)을 출시했다. 세계 시장을 선도하는 Imaris 소프트웨어의 이번 업데이트는 단계별 워크플로우(Workflows), 강화된 배치 처리, 고급 객체 감지 및 통계 분석 기능을 중심으로 생명과학 연구 소프트웨어 사용자들의 생산성과 분석 효율을 높이는 데 초점을 맞췄다. '워크플로우'로 생산성 향상 Imaris 11의 핵심은 새롭게 도입된 워크플로우(Workflows) 기능이다. 사용자는 소프트웨어 내에서 단계별 프로토콜을 직접 생성•저장•공유할 수 있으며, 분석 과정을 단계별로 안내하여 초보자와 숙련된 사용자도 편리하게 사용할 수 있다. 워크플로우는 데이터 세트나 여러 사용자 간에 내보내기•가져오기가 가능해 다자간 협업과 연구 재현성을 크게 개선하며, 배치 프로토콜(Batch protocols)로도 작동해 자동화 분석을 수행하면서, 필요 시 중간 단계에서
SINGAPORE, Dec. 1, 2025 -- MetaOptics Ltd (Catalist: 9MT) ("MetaOptics" or the "Company", and together with its subsidiaries, the "Group"), a leading-edge semiconductor optics company, announced that it is proposing to raise S$4.85 million through a placement of 6,685,028 new ordinary shares in the capital of the Company ("Placement Shares") at S$0.7255 per Placement Share ("Share Placement"). The proceeds from the Share Placement are expected to (i) strengthen the Group's financial position and expand the capital base of the Group to s
BANGKOK, Dec. 1, 2025 -- Malaysia had a rare moment of reflection this year when former Prime Minister Tun Dr. Mahathir Mohamad turned 100. His milestone sparked public conversations about aging, vitality, and what it truly means to remain strong at any age. For many, longevity still feels like a mystery. For Prof. Dato' Sri Dr. Mike Chan, it is a science — one he has spent more than 40 years studying, researching teaching, and refining across Americas, Europe and Asia. At the We Are The World Global Summit in Bangkok, Prof. Chan who represents the European Wellness Biom
KOTA KINABALU, Malaysia, Dec. 1, 2025 -- Big changes often start in small ways. For Sabah FC, a top Malaysian football club, it began with a simple agreement — a partnership with European Wellness, a medical group best known for anti-aging and precursor stem cell therapy. But that one move is now shaking up the world of sports medicine. Because what started in Sabah is now heading to the biggest sporting stage in the world: the Super Bowl. And behind it all is a man who's been preparing for this moment for over 40 years — Prof. Dato' Sri Dr. Mike Chan. How
KUALA LUMPUR, Malaysia, Nov. 30, 2025 -- Malaysia's drive to modernize autism care received strong support today when the Raja Muda of Perlis, Tuanku Syed Faizuddin Putra Jamalullail, and his consort, Tuanku Dr. Hajah Lailatul Shahreen Akashah Khalil, attended the International Congress on Advances in Autism, Neurodevelopmental & Neurodegenerative Disorders (ICAANND 2025) in Kuala Lumpur. Their appearance signalled rising national commitment to early diagnosis, intervention capacity and improved support for neurodiverse families. ICAANND 2025 was organized by the European Wellness Biomedi
- Utilizing Ascletis' Peptide Oral Transport ENhancement Technology (POTENT), ASC37 oral tablets achieved average absolute oral bioavailability of 4.2%, approximately 9-, 30-, and 60-fold higher than semaglutide, tirzepatide, and retatrutide in the oral SNAC formulation, respectively, in head-to-head non-human primate (NHP) studies. - ASC37 oral tablets' drug exposure, as measured by the area under curve (AUC), was approximately 57-fold of retatrutide's drug exposure in head-to-head NHP studies. - Average observed half-life of ASC37 oral tablets was approximately 56 hours in N
SHANGHAI, Nov. 30, 2025 -- On the afternoon of November 26, a major Grade 5 fire spread across multiple residential buildings in Wang Fuk Court in Tai Po, Hong Kong, causing severe casualties and drawing widespread public concern. In response, on November 28, Qiming Venture Partners made a donation of HK$3 million to the Tai Po Wang Fuk Court Aid Fund established by the Hong Kong SAR Government, to support affected residents and contribute to post-disaster reconstruction. The Hong Kong SAR Government established the Tai Po Wang Fuk Court Aid Fund on November 27, with an initial allocat
[ 메디채널 김갑성 기자 ] 시안, 중국 2025년 11월 29일 -- 텐룽(Tianlong)이 2025년 세계 에이즈의 날을 맞아 일체형 핵산 혈액 검사 솔루션을 공개하면서 더 진보한 전 세계 수혈 안전성에 대한 헌신을 다시 한번 천명했다. 이 솔루션은 고감도 NAT 시약을 고도로 자동화해 결합한 제품으로 저바이러스 부하 감염을 조기에 검출하는 역할을 한다. 이는 수혈로 인한 HIV 감염을 줄이고 안전한 혈액이 필요한 환자를 보호하는 데 필수적인 단계다. 조기 발견으로 혈액 안전성 강화 혈액 안전성 확보는 수혈로 인한 감염을 가장 효과적으로 막는 수단이다. 텐룽은 검사 정확도를 높이고 실험실에서 HBV, HCV, HIV-1, HIV-2를 조기에 발견해 전 세계 공중 보건 활동을 지원하는 한편 헌혈 받은 혈액에 대한 신뢰도를 높이고 있다. 혈액 스크리닝 적용을 위한 완전 자동화 워크플로 텐룽 솔루션의 핵심은 혈액 센터와 대규모 스크리닝 프로그램에 맞춰 개발한 Aurora PANA X6 전자동 핵산 추출 시스템이다. Gentier 96 Real-time PCR System과 함께
HONG KONG, Nov. 29, 2025 -- In response to the devastating No. 5 alarm fire at Wang Fuk Court, Tai Po, ANKH Pain Relief Health Group has donated HK$1 million to the Hong Kong Red Cross to support their "Tai Po Fire Emergency Appeal". The major blaze at Wang Fuk Court has caused serious casualties and left thousands of residents homeless. The Hong Kong Red Cross has swiftly activated its emergency response mechanism to assist those affected, providing on-site first aid, emergency cash assistance, essential daily supplies, psychological support services, and post-disaster recov